Related Experiment Video

Updated: May 16, 2026

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
04:43

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah

Published on: June 24, 2025

Epidemiology of viral hepatitis in Saudi Arabia: are we off the hook?

Ayman A Abdo1, Faisal M Sanai, Faleh Z Al-Faleh

  • 1Department of Medicine, Gastroenterology Unit, King Khalid University Hospital, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association
|November 15, 2012
PubMed

Insights

Viral hepatitis, including hepatitis B (HBV) and hepatitis C (HCV), remains a global health concern. This review documents the epidemiological timeline of viral hepatitis in Saudi Arabia, highlighting disease trends and healthcare impacts.

Area of Science:

  • Epidemiology
  • Public Health
  • Virology

Background:

  • Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections affect millions globally, representing a significant epidemic.
  • Despite declining prevalence in Saudi Arabia, HBV and HCV cause substantial morbidity, mortality, and healthcare burdens.
  • Hepatitis A virus (HAV) seroprevalence has notably decreased in Saudi Arabia over the last two decades.

Purpose of the Study:

  • To document the epidemiological timeline of viral hepatitis in Saudi Arabia.
  • To summarize published literature on viral hepatitis epidemiology within the country.
  • To identify gaps in understanding the clinical expression of viral hepatitis.

Main Methods:

  • Literature review of published studies on viral hepatitis epidemiology in Saudi Arabia.
  • Analysis of epidemiological data and trends over time.
  • Synthesis of information regarding disease prevalence, morbidity, and mortality.

Main Results:

  • Significant decline in HBV and HCV prevalence in Saudi Arabia noted.
  • Substantial ongoing burden of HBV and HCV infection on healthcare systems.
  • Considerable reduction in HAV seroprevalence over the past 20 years.

Conclusions:

  • Viral hepatitis epidemiology in Saudi Arabia shows evolving patterns.
  • Continued monitoring and research are essential to address remaining challenges and clinical expression details.
  • Progress in understanding viral hepatitis trends aids public health strategies.

More Related Videos

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...